Back to News
Market Impact: 0.18
Hofseth BioCare ASA: PRIMARY INSIDER NOTIFICATION
Source: GlobeNewswire
Insider TransactionsManagement & GovernanceHealthcare & Biotech
Hofseth BioCare board member and primary insider Christoph Baldegger purchased 2.5 million HBC shares in an off-market transaction at an average price of NOK 1.13 per share on 17 September 2026. The NOK 2.83 million purchase signals insider confidence but is unlikely to have broad market impact.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
HBC0.45
More News
- Jana Partners pushes Cooper to replace CEO, weigh asset sales- WSJ
- Halozyme prices $1.3 billion convertible notes offering
- FDA approves Ultragenyx’s Fayuvi for Sanfilippo syndrome Type A
- Why is Xenon Pharmaceuticals stock plunging today?
- Intel and Micron lead our portfolio higher, and J&J's strengthens our case for owning it
- CoreWeave CEO Michael Intrator reports $25.2 million stock sale